A pilot study of gene expression-based categorization of pancreas transplant biopsies

Transplantation

Volumn 87, Issue 2, 2009, Pages 222-226

  Luan, Fu L ^a,c   Trillsch, Fabian ^b   Henger, Anna ^a   Eichinger, Felix ^a   Norman, Silas ^a   Appelman, Henry ^a   Kretzler, Matthias ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MUNICH   (Germany)

^c Box 0364 ^*  (United States)

Author keywords

Gene profiling; Pancreas transplant biopsy; Rejection

Indexed keywords

AMYLASE; CD20 ANTIBODY; CD3 ANTIGEN; CELL PROTEIN; CHOLECYSTOKININ A RECEPTOR; ELASTASE; GLUCAGON; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INSULIN; MESSENGER RNA; PROTEIN MS4A1; PROTEIN POLR2A; PROTEIN PPIA; PROTEIN UBC; RNA 18S; SOMATOSTATIN; TRANSCRIPTION FACTOR MAF; TRANSCRIPTION FACTOR MAFB; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; KIDNEY GRAFT REJECTION; MALE; PANCREAS BIOPSY; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; ALLOTRANSPLANTATION; BIOPSY; CHEMISTRY; CLUSTER ANALYSIS; DNA MICROARRAY; FEASIBILITY STUDY; GENETICS; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOLOGY; METHODOLOGY; MIDDLE AGED; PANCREAS; PATHOLOGY; PILOT STUDY; POLYMERASE CHAIN REACTION; PREDICTION AND FORECASTING; RETROSPECTIVE STUDY; TIME; TREATMENT OUTCOME;

ADULT; BIOPSY; CLUSTER ANALYSIS; FEASIBILITY STUDIES; GENE EXPRESSION PROFILING; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PANCREAS; PANCREAS TRANSPLANTATION; PILOT PROJECTS; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RNA, MESSENGER; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 59649092402     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31818c8fbf     Document Type: Article

References (20)

1. Robertson RP, Davis C, Larsen J, et al. Pancreas transplantation for patients with type 1 diabetes. Diabetes Care 2003; 26 (Suppl 1): S120.
2. Mai ML, Ahsan N, Gonwa T. The long-term management of pancreas transplantation. Transplantation 2006; 82: 991.
3. Papadimitriou JC, Drachenberg CB, Wiland A,et al. Histologic grading of acute allograft rejection in pancreas needle biopsy: Correlation to serum enzymes, glycemia, and response to immunosuppressive treatment. Transplantation 1998; 66: 1741.
4. Humar A, Khwaja K, Ramcharan T, et al. Chronic rejection: The next major challenge for pancreas transplant recipients. Transplantation 2003; 76: 918.
5. Drachenberg CB, Papadimitriou JC, Klassen DK, et al. Evaluation of pancreas transplant needle biopsy: Reproducibility and revision of histologic grading system. Transplantation 1997; 63: 1579.
6. Lipman ML, Stevens AC, Strom TB. Heightened intragraft CTL gene expression in acutely rejecting renal allografts. J Immunol 1994; 152: 5120.
7. Mueller TF, EineckeG, Reeve J,et al. Microarray analysisof rejection in human kidney transplants using pathogenesis-based transcript sets. Am J Transplant 2007; 7: 2712.
8. Sarwal M, Chua MS, Kambham N, et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 2003; 349: 125.
9. Cohen CD, Gröne HJ, Gröne EF, et al. Laser microdissection and gene expression analysis on formaldehyde-fixed archival tissue. Kidney Int 2002; 61: 125.
10. Fink L, Seeger W, Ermert L, et al. Real-time quantitative RT-PCR after laser-assisted cell picking. Nat Med 1998; 4: 1329.
11. Eisen MB, Spellman PT, Brown PO, et al. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998; 95: 14863.
12. Strehlau J, Pavlakis M, Lipman M, et al. Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. Proc Natl Acad Sci USA 1997; 94: 695.
13. Li B, Hartono C, Ding R, et al. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med 2001; 344: 947.
14. Sharma VK, Bologa RM, Li B, et al. Molecular executors of cell death-differential intrarenal expression of Fas ligand, Fas, granzyme B, and perforin during acute and/or chronic rejection of human renal allografts. Transplantation 1996; 62: 1860.
15. Cashion AS, Driscoll O, Gaber C, et al. Correlation of genetic markers of rejection with biopsy findings following human pancreas transplant. Clin Transplant 2005; 20: 106.
16. Han D, Xu X, Baidal D, et al. Assessment of cytotoxic lymphocyte gene expression in the peripheral blood of human islet allograft recipients: Elevation precedes clinical evidence of rejection. Diabetes 2004; 53: 2281.
17. Gruessner AC, Sutherland DE. Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004. Clin Transplant 2005; 19: 433.
18. Casey ET, Smyrk TC, Burgart LJ, et al. Outcome of untreated grade II rejection on solitary pancreas allograft biopsy specimens. Transplantation 2005; 79: 1717.
19. Carbajal R, Karam G, Renaudin K, et al. Specific humoral rejection of a pancreas allograft in a recipient of pancreas after kidney transplantation. Nephrol Dial Transplant 2007; 22: 942.
20. Melcher ML, Olson JL, Baxter-Lowe LA, et al. Antibody-mediated rejection of a pancreas allograft. Am J Transplant 2006; 6: 423.